Switzerland Coagulation Testing Marketion Chromogenic and Immunodiagnostic Hemostasis Tests Latest Technologies Instrumentation Pipeline
This comprehensive report from is designed to help current suppliers and potential market entrants identify and evaluate emerging business opportunities during the next five years.
The report is available by section, and can be customized to specific information needs and budget.
The report explores market and technological trends; provides reagent, instrument and test volume for 40 coagulation procedures; compares features of major analyzers; profiles leading market players; and identifies specific product and business opportunities facing instrument and consumable suppliers during the next five years.
Coagulation Tests Analyzed in the Report
Activated Clotting Time (ACT) (1), Activated Protein C Resistance, Activated PTT (APTT), Alpha 2-Antiplasmin, Antithrombin III, Bleeding Time, D-Dimer, Factor II, Factor V, Factor V Leiden, Factor VII, Factor VIII, Factor IX, Factor Ixa, Factor X (Stuart Factor), Factor Xa, Factor XI, Factor XII, Factor XIII, Fibrin Degradation Products, Fibrinogen, Fletcher Factor/Pre-Kallikrein Factor Activation, Heparin/Anti-Factor Xa, Heparin-Induced Thrombocytopenia, Plasmin, Plasminogen, Plasminogen Activator Inhib., Platelet Function/Aggregation, Protein C, Protein S, Prothrombin Mutation, Prothrombin Time (PT), Reptilase Time, Thrombin Time, Von Willebrands Factor Fav/Ag, and others.
Competitive Assessments
- Extensive strategic profiles of major suppliers and emerging market entrants.
Current and Emerging Products
- Review of established and emerging procedures.
- Comparison of automated and semi-automated analyzers.
Technology Review
- Analysis of current and emerging technologies and their potential market applications.
- Comprehensive listings of companies developing or marketing new technologies and products by test.
Strategic Recommendations
- Product development and business expansion opportunities with significant market appeal.
- Alternative market penetration strategies for instrument and reagent suppliers.
- Potential market entry barriers and risks.
II. Market Overview
A. Major Routine and Special Coagulation Tests
1. Introduction
2. Activated Partial Thromboplastin Time (APTT)
3. Alpha-2 Antiplasmin
4. Antithrombin III
5. Bleeding Time
6. D-Dimer
7. Ethanol Flocculation Test
8. Euglobulin Lysis
9. Factor Assays
a. Introduction
b. Factor II
c. Factor V/Factor V Leiden
d. Factor VII
e. Factor VIII
f. Factor IX
g. Factor IXa
h. Factor X (Stuart Factor)
i. Factor Xa
j. Factor XI
k. Factor XII
l. Factor XIII
10. Fibrin Degradation Products
11. Fibrinogen
12. Heparin
13. Hirudin
14. Hypercoagulability and Thrombosis
15. Lipoprotein a
16. Plasmin
17. Plasminogen
18. Plasminogen Activator Inhibitor (PAI)
19. Platelet Function Tests
20. Platelet Aggregation
21. Proteins C and S
22. Prothrombin Fragment 1.2
23. Prothrombin Time (PT)
24. Reptilase Time
25. Thrombin Time
26. Tissue-Type Plasminogen Activator (t-PA)
27. Von Willebrands Factor
B. Instrumentation Review
C. Major Technologies and Applications
III. Market Size and Growth: Forecasts for 40 Coagulation Procedures, Reagents and Instruments
IV. Major Product Development Opportunities
V. Design Criteria for Decentralized Testing Products
VI. Alternative Market Penetration Strategies
VII. Potential Market Entry Barriers and Risks
VIII. Competitive Assessments
The report provides strategic assessments of over 20 leading coagulation market
players and start-up companies with innovative technologies and
products, including:
Abbott
Beckman Coulter/Danaher
Becton Dickinson
Diagnostica Stago
Grifols
Helena Laboratories
IL/Werfen
Roche
Sekisui Diagnostics
Siemens Healthineers
Sysmex
Thermo Fisher, and others
List Of Tables
Coagulation Test Volume Forecasts by ProcedureCoagulation Diagnostics Market by Product Category
Major Companies Developing or Marketing Activated Clotting Time Tests
Major Companies Developing or Marketing APTT Tests
Major Companies Developing or Marketing Alpha-2 Antiplasmin Tests
Major Companies Developing or Marketing Antithrombin III Tests
Major Companies Developing or Marketing Bleeding Time Tests
Major Companies Developing or Marketing D-dimer Tests
Major Companies Developing or Marketing Factor Assays
Major Companies Developing or Marketing Fibrin Degradation Product Tests
Major Companies Developing or Marketing Fibrinogen Tests
Major Companies Developing or Marketing Heparin Tests
Major Companies Developing or Marketing Plasmin Tests
Major Companies Developing or Marketing Plasminogen Tests
Major Companies Developing or Marketing Plasminogen Activator Inhibitor Tests
Major Companies Developing or Marketing Platelet Aggregation Tests
Major Companies Developing or Marketing Protein C Tests
Major Companies Developing or Marketing Protein S Tests
Major Companies Developing or Marketing PT Tests
Major Companies Developing or Marketing Thrombin Time Tests
Major Companies Developing or Marketing TPA Tests
Major Companies Developing or Marketing Von Willebrands Factor Tests
Whats Next for Switzerland Diagnostics Market? Supplier Shares and Strategies
Whats Next for Switzerland Diagnostics Market Supplier Shares and StrategiesThis new report provides granular analysis of the diagnostic testing market, including 2023 supplier shares, strategies, as well as 2023-2028 volume
USD 3500 View ReportSwitzerland Nucleic Acid Testing Market Opportunities
Switzerland Nucleic Acid Testing Market OpportunitiesThis new report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the molecular diagnostics market during the
USD 2450 View Report2024 POC Coagulation Testing Market Supplier Shares Strategies Volume Sales Segment Forecasts Physician Offices Emergency Rooms Operating Suites ICUs/CCUs Cancer Clinics Ambulatory
2024 POC Coagulation Testing Market: 2023 Supplier Shares and Strategies, 2023-2028 Volume and Sales Segment Forecasts for Physician Offices, Emergency Rooms, Operating Suites, ICUs/CCUs, Cancer Clinics, Ambulatory Care Centers, Surgery
USD 4500 View Report2024 POC Coagulation Testing Forecasts Assays Supplier Shares Physician Offices ER OR ICU Cancer Clinics Ambulatory Care Surgery Birth Centers Nursing Homes Instrumentation Review Emerging Technologies
2024 POC Coagulation Testing Forecasts for 40 Assays and 2023 Supplier Shares: Physician Offices, ER, OR, ICU, Cancer Clinics, Ambulatory Care, Surgery and Birth Centers, Nursing Homes--Instrumentation Review, Emerging TechnologiesThis
USD 7500 View ReportFill The Form For Sample Request